Topic: Type 2 diabetes

Join Zhichao Zhou’s research at BioClinicum to investigate red-blood-cell signalling and vascular complications of type 2 diabetes. The project studies noncoding RNA and related mechanisms using clinical material, rodent models, cell culture, extracellular vesicles and vascular functional assays. Methods include myography, immunohistochemistry, immunoblotting and quantitative PCR. The position is full time and temporary. Apply online by 14 October 2026 with the documents specified in the employer’s advert.

The increasing prevalence of obesity and type 2 diabetes (T2D) and associated morbidity and mortality emphasizes the need for a more complete understanding of the mechanisms mediating energy homeostasis to accelerate the identification of new medications. Recent reports indicate that obesity medication, 5-hydroxytryptamine (5-HT, serotonin)2C receptor (5-HT2CR) agonist lorcaserin improves glycemic control in association with weight loss in obese patients with T2D. We examined whether lorcaserin has a direct effect on insulin sensitivity and how this effect is achieved. We clarify that lorcaser